NCT03011177View on ClinicalTrials.gov

Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

168

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG

Teneligliptin

teneligliptin 20mg qd

DRUG

Linagliptin

linagliptin 5mg qd

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Handok Inc.

INDUSTRY